title: Mediastinitis in heart transplantation.
abstract: Between March 1985 and December 1991, mediastinitis developed in 12 of 420 cardiac transplantation patients (2.8%). The mortality rate in this group of patients was 8.3% (1/12). Actuarial survival (1 year, 75%; and 5 years, 65%) was not significantly different from that of the group without mediastinitis (1 year, 88%; and 5 years, 75%). A higher percentage of the patients in the group with mediastinitis were listed as UNOS status 1 (50% versus 35%) and had a history of previous sternotomies (58% versus 44%). The presentation of mediastinitis was typical. Computed tomographic scanning with or without aspiration was a valuable adjunct in the diagnosis of mediastinitis. Induction immunotherapy with minimal steroids in the perioperative period was used in all patients. This may contribute to the patients' ability to mount an appropriate and effective response to infection, permitting earlier diagnosis. The debridement irrigation technique used in 8 of 12 patients had a low success rate of 33%, whereas the debridement muscle flap technique used in 4 of 12 was 100% successful in eliminating infection.
authors.affiliation: Division of Cardiothoracic Surgery, University of Utah School of Medicine, Salt Lake City 84132.
authors.forename: S V
authors.initials: SV
authors.lastname: Karwande
authors.forename: D G
authors.initials: DG
authors.lastname: Renlund
authors.forename: S L
authors.initials: SL
authors.lastname: Olsen
authors.forename: W A
authors.initials: WA
authors.lastname: Gay
authors.forename: W E
authors.initials: WE
authors.lastname: Richenbacher
authors.forename: J A
authors.initials: JA
authors.lastname: Hawkins
authors.forename: R C
authors.initials: RC
authors.lastname: Millar
authors.forename: J D
authors.initials: JD
authors.lastname: Marks
mesh_terms: D000206:Actuarial Analysis; D003646:Debridement / Q000592:standards; D005260:Female; D006084:Graft Rejection / Q000276:immunology; D016027:Heart Transplantation / Q000009:adverse effects* / Q000276:immunology; D006755:Hospital Shared Services; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods / Q000592:standards; D015994:Incidence; D016015:Logistic Models; D008297:Male; D008480:Mediastinitis / Q000175:diagnosis / Q000453:epidemiology* / Q000628:therapy; D011183:Postoperative Complications / Q000175:diagnosis / Q000453:epidemiology* / Q000628:therapy; D012189:Retrospective Studies; D012307:Risk Factors; D012720:Severity of Illness Index; D013396:Suction / Q000592:standards; D013524:Surgical Flaps / Q000592:standards; D016019:Survival Analysis; D014057:Tomography, X-Ray Computed / Q000592:standards; D014181:Transplantation Immunology; D014589:Utah / Q000453:epidemiology